Webinar - Quantifying T cell exhaustion:  An insight into BiTE antibodies and CAR-T cells for improved therapeutics

If you are a biotech scientist interested in reversing or overcoming the state of T cell exhaustion, this webinar will show you how advanced flow cytometry can be used to effectively evaluate immuno-oncology drugs using physiologically relevant assays.

What you will learn from this webinar:

• It will give you a better understanding of how advanced flow cytometry can be used to effectively evaluate immuno-oncology drugs using physiologically relevant assays.
• You will understand how to predict how drugs will work in vivo. This is an important factor in their development and this webinar will show how in vitro assays can be used to do this.
• The end-to end solution for therapeutic drug interrogation outlined in this talk will provide you with a significant advantage by creating an environment for fast, accurate decision making, speeding up the drug discovery process.
• This webinar highlights how the iQue3 and the T cell exhaustion cell and cytokine kit can be used together to rapidly quantify both phenotype and function.

About the speaker: Lauren Kelsey is a scientist in the iQue® applications group, part of the European based BioAnalytics at Sartorius, where she is involved in the research and development of novel applications. Kelsey’s efforts are focused on the iQue®3 advanced flow cytometry platform where she has supported a number of the immuno-oncology campaigns that are used to exemplify how our technology can be applied to the drug discovery process. Kelsey obtained a degree in Biology at the University of Bath and went on to complete a masters in Regenerative Medicine where she studied mouse pancreatic and liver development before joining Sartorius as an Associate Scientist in 2018